vs

Side-by-side financial comparison of CONSUMER PORTFOLIO SERVICES, INC. (CPSS) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $109.4M, roughly 1.8× CONSUMER PORTFOLIO SERVICES, INC.). REPLIGEN CORP runs the higher net margin — 6.7% vs 4.6%, a 2.2% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 3.9%). CONSUMER PORTFOLIO SERVICES, INC. produced more free cash flow last quarter ($288.3M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 9.2%).

Consumer Portfolio Services, Inc. is a U.S. specialty finance firm providing indirect auto loan financing and servicing for consumers with limited or subprime credit. It partners with franchised and independent car dealerships nationwide to originate installment contracts for new and used vehicle purchases.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

CPSS vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.8× larger
RGEN
$197.9M
$109.4M
CPSS
Growing faster (revenue YoY)
RGEN
RGEN
+9.7% gap
RGEN
13.6%
3.9%
CPSS
Higher net margin
RGEN
RGEN
2.2% more per $
RGEN
6.7%
4.6%
CPSS
More free cash flow
CPSS
CPSS
$270.7M more FCF
CPSS
$288.3M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
9.2%
CPSS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPSS
CPSS
RGEN
RGEN
Revenue
$109.4M
$197.9M
Net Profit
$5.0M
$13.3M
Gross Margin
52.5%
Operating Margin
6.6%
9.0%
Net Margin
4.6%
6.7%
Revenue YoY
3.9%
13.6%
Net Profit YoY
-3.2%
143.9%
EPS (diluted)
$0.21
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPSS
CPSS
RGEN
RGEN
Q4 25
$109.4M
$197.9M
Q3 25
$108.4M
$188.8M
Q2 25
$109.8M
$182.4M
Q1 25
$106.9M
$169.2M
Q4 24
$105.3M
$174.1M
Q3 24
$100.6M
$154.9M
Q2 24
$95.9M
$154.1M
Q1 24
$91.7M
$151.3M
Net Profit
CPSS
CPSS
RGEN
RGEN
Q4 25
$5.0M
$13.3M
Q3 25
$4.9M
$14.9M
Q2 25
$4.8M
$14.9M
Q1 25
$4.7M
$5.8M
Q4 24
$5.1M
$-30.3M
Q3 24
$4.8M
$-654.0K
Q2 24
$4.7M
$3.3M
Q1 24
$4.6M
$2.1M
Gross Margin
CPSS
CPSS
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
CPSS
CPSS
RGEN
RGEN
Q4 25
6.6%
9.0%
Q3 25
6.5%
8.9%
Q2 25
6.3%
7.6%
Q1 25
6.4%
3.9%
Q4 24
7.0%
-17.7%
Q3 24
6.8%
-5.1%
Q2 24
7.0%
1.0%
Q1 24
7.1%
1.3%
Net Margin
CPSS
CPSS
RGEN
RGEN
Q4 25
4.6%
6.7%
Q3 25
4.5%
7.9%
Q2 25
4.4%
8.2%
Q1 25
4.4%
3.4%
Q4 24
4.9%
-17.4%
Q3 24
4.8%
-0.4%
Q2 24
4.9%
2.2%
Q1 24
5.0%
1.4%
EPS (diluted)
CPSS
CPSS
RGEN
RGEN
Q4 25
$0.21
$0.24
Q3 25
$0.20
$0.26
Q2 25
$0.20
$0.26
Q1 25
$0.19
$0.10
Q4 24
$0.21
$-0.55
Q3 24
$0.20
$-0.01
Q2 24
$0.19
$0.06
Q1 24
$0.19
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPSS
CPSS
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$6.3M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$309.5M
$2.1B
Total Assets
$3.9B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPSS
CPSS
RGEN
RGEN
Q4 25
$6.3M
$767.6M
Q3 25
$9.4M
$748.7M
Q2 25
$15.8M
$708.9M
Q1 25
$29.8M
$697.2M
Q4 24
$11.7M
$757.4M
Q3 24
$8.1M
$784.0M
Q2 24
$9.8M
$809.1M
Q1 24
$13.2M
$780.6M
Total Debt
CPSS
CPSS
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CPSS
CPSS
RGEN
RGEN
Q4 25
$309.5M
$2.1B
Q3 25
$307.6M
$2.1B
Q2 25
$303.1M
$2.1B
Q1 25
$298.4M
$2.0B
Q4 24
$292.8M
$2.0B
Q3 24
$285.1M
$2.0B
Q2 24
$280.3M
$2.0B
Q1 24
$279.1M
$2.0B
Total Assets
CPSS
CPSS
RGEN
RGEN
Q4 25
$3.9B
$2.9B
Q3 25
$3.8B
$2.9B
Q2 25
$3.8B
$2.9B
Q1 25
$3.7B
$2.9B
Q4 24
$3.5B
$2.8B
Q3 24
$3.5B
$2.8B
Q2 24
$3.3B
$2.9B
Q1 24
$3.0B
$2.8B
Debt / Equity
CPSS
CPSS
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPSS
CPSS
RGEN
RGEN
Operating Cash FlowLast quarter
$289.0M
$25.7M
Free Cash FlowOCF − Capex
$288.3M
$17.6M
FCF MarginFCF / Revenue
263.5%
8.9%
Capex IntensityCapex / Revenue
0.6%
4.1%
Cash ConversionOCF / Net Profit
58.02×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$500.9M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPSS
CPSS
RGEN
RGEN
Q4 25
$289.0M
$25.7M
Q3 25
$84.9M
$48.1M
Q2 25
$54.5M
$28.6M
Q1 25
$73.9M
$15.0M
Q4 24
$233.8M
$39.2M
Q3 24
$69.8M
$49.3M
Q2 24
$43.3M
$42.2M
Q1 24
$52.7M
$44.7M
Free Cash Flow
CPSS
CPSS
RGEN
RGEN
Q4 25
$288.3M
$17.6M
Q3 25
$84.9M
$43.4M
Q2 25
$54.3M
$21.5M
Q1 25
$73.4M
$11.4M
Q4 24
$233.3M
$33.6M
Q3 24
$69.7M
$42.3M
Q2 24
$43.1M
$37.4M
Q1 24
$52.6M
$36.4M
FCF Margin
CPSS
CPSS
RGEN
RGEN
Q4 25
263.5%
8.9%
Q3 25
78.3%
23.0%
Q2 25
49.5%
11.8%
Q1 25
68.7%
6.8%
Q4 24
221.6%
19.3%
Q3 24
69.3%
27.3%
Q2 24
45.0%
24.3%
Q1 24
57.3%
24.0%
Capex Intensity
CPSS
CPSS
RGEN
RGEN
Q4 25
0.6%
4.1%
Q3 25
0.0%
2.5%
Q2 25
0.1%
3.9%
Q1 25
0.4%
2.1%
Q4 24
0.4%
3.2%
Q3 24
0.1%
4.5%
Q2 24
0.2%
3.1%
Q1 24
0.1%
5.5%
Cash Conversion
CPSS
CPSS
RGEN
RGEN
Q4 25
58.02×
1.93×
Q3 25
17.50×
3.23×
Q2 25
11.35×
1.92×
Q1 25
15.74×
2.57×
Q4 24
45.43×
Q3 24
14.55×
Q2 24
9.27×
12.70×
Q1 24
11.48×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons